AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUTEP LTD

0.050

0.000

Volume:2.52M

Turnover:125.26K

Market Cap:73.69M

PE:-0.87

High:0.051

Open:0.050

Low:0.049

Close:0.050

52wk High:0.470

52wk Low:0.028

Shares:1.47B

Float Shares:1.23B

Volume Ratio:0.74

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.057

EPS(LYR):-0.042

ROE:-61.85%

ROA:-32.10%

PB:0.75

PE(LYR):-1.18

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-1.25%

Capital Flow

Inflow:

Outflow:

News

Immutep Says Eftisarc-neo Phase II Eposter on Efti Hrqol in Soft Tissue Sarcoma Accepted for ESMO 2026

Immutep Receives New US Patent for Cancer Treatment Method; Shares Down 4%

MT Newswires Live

Immutep Provides Clinical Update in 1st Line Nsclc: Positive Mature Overall Survival Data from Insight-003 and Update from Tacti-004

THOMSON REUTERS

Immutep - Insight-3 Shows Mature Median Overall Survival of 30.9 Months in 1L Non-squamous Nsclc

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IMM.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","market":"AU","secType":"STK","nameCN":"IMMUTEP LTD","latestPrice":0.05,"timestamp":1787897520000,"preClose":0.05,"halted":0,"volume":2519726,"delay":0,"changeRate":0,"nameEN":"IMMUTEP LTD","floatShares":1228247159,"shares":1473721306,"eps":-0.057294,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-28 16:12:00 AEST","open":0.05,"high":0.051,"low":0.049,"amount":125259,"amplitude":0.04,"askPrice":0.051,"askSize":109018,"bidPrice":0.049,"bidSize":1083262,"shortable":3,"etf":0,"ttmEps":-0.057294,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788134400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.05,"openAndCloseTimeList":[[1787875200000,1787896800000]],"volumeRatio":0.7414129453835181,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMM.AU","preClose":0.05,"auctionPrice":0.05,"auctionVolume":314287,"auction":3,"marketStatus":"盘后竞价","timestamp":1787897404544}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMM.AU\",,,,,undefined,":{"symbol":"IMM.AU","floatShares":1228247159,"roa":"-32.10%","roe":"-61.85%","lyrEps":-0.042199,"volumeRatio":0.7414129453835181,"shares":1473721306,"dividePrice":0,"high":0.051,"amplitude":0.04,"preClose":0.05,"low":0.049,"week52Low":0.028,"pbRate":"0.75","psRate":"9.30","week52High":0.47,"institutionHeld":0,"latestPrice":0.05,"committee":0.817127,"eps":-0.057294,"divideRate":0,"volume":2519726,"delay":0,"ttmEps":-0.057294,"open":0.05,"prevYearClose":0.415,"prevWeekClose":0.05,"prevMonthClose":0.046,"prevQuarterClose":0.053,"fiveDayClose":0.053,"twentyDayClose":0.046,"sixtyDayClose":0.05,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-06-05","symbol":"IMM.AU","defaultRemindTime":1717545600000,"type":"split","dateTimestamp":1717509600000,"forFactor":948148,"toFactor":1000000,"ratio":0.9481480000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMM.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653084916","title":"Immutep Says Eftisarc-neo Phase II Eposter on Efti Hrqol in Soft Tissue Sarcoma Accepted for ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084916","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084916?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:05","pubTimestamp":1784894709,"startTime":"0","endTime":"0","summary":"Immutep says EFTISARC-NEO Phase II ePoster on efti HRQoL in soft tissue sarcoma accepted for ESMO 2026Immutep flagged an accepted ESMO Congress 2026 ePoster from the Phase II EFTISARC-NEO trial of eft","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL3Nl1BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651126444","title":"Immutep Receives New US Patent for Cancer Treatment Method; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651126444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651126444?lang=en_us&edition=fundamental","pubTime":"2026-07-14 11:25","pubTimestamp":1783999558,"startTime":"0","endTime":"0","summary":"Immutep  obtained a fourth patent from the US Patent and Trademark Office related to its cancer treatments, according to a Tuesday filing with the Australian bourse.The new patent, which covers methods to treat cancer by administering eftilagimod alfa in combination with PD-1 pathway inhibitors, has an expiry date of Jan. 20, 2036, per the filing.The company is evaluating eftilagimod alfa in a variety of solid tumors, including non-small cell lung cancer, head and neck squamous cell carcinoma, soft tissue sarcoma, and breast cancer.Immutep shares fell nearly 4% in recent Tuesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","IMM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651811966","title":"Immutep Provides Clinical Update in 1st Line Nsclc: Positive Mature Overall Survival Data from Insight-003 and Update from Tacti-004","url":"https://stock-news.laohu8.com/highlight/detail?id=2651811966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651811966?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:00","pubTimestamp":1783944003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA2HW17Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196131","title":"Immutep - Insight-3 Shows Mature Median Overall Survival of 30.9 Months in 1L Non-squamous Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651196131?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:00","pubTimestamp":1783944003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA2HW17Z:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMM.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.012496}]}}